Intermountain Cancer Centers use proven and innovative cancer treatment techniques and technologies to provide you with the most advanced care. Precision Genomics is a robust part of these innovative approaches, holding tremendous promise for cancer patients around the world.
Working at the forefront of medical science, Intermountain Precision Genomics uses state-of-the-art genomic technology to understand and fight different types of cancer. Our physicians and scientists sequence and analyze the DNA of individual tumors and evaluate which specific mutations might be making a cancer grow. With Intermountain Biorepository, a central data source of biologic samples and linked clinical data, we can determine new biomarkers and other discoveries to yield new treatment options.
For more than 80 percent of patients with advanced-stage cancer, Intermountain is able to identify actionable mutations and offer additional treatment options to target the mutations. These options are usually therapies given as a pill that patients can take at home with fewer side effects and often at the same or lower cost than traditional chemotherapy.